Fact CheckerSign in

NCT04319146Active, not recruiting

Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer

Pilot Feasibility Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer

Source: ClinicalTrials.gov · Last updated 4 Dec 2025

Brief summary (registry, in English)

The promoter propose a pilot study evaluating the feasability of robot-assisted radical prostatectomy on outpatient in patients with localized prostate cancer. This study will enrole a total of 20 patients over one center, followed for 1 month. The total study duration will be 15 months, including statistical analysis and publication.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
17 Mar 2020
Start date
25 Jan 2022
Primary completion date
Dec 2025
Lead sponsor
Centre Hospitalier Universitaire de Nice
NCT number
NCT04319146

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 25 Jan 2022 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Taking the following drugs within 48 hours (Plavix®, anti-vitamin K / curative LMWH)

Other illness

  • History of major abdominal surgery
  • History of pelvic radiotherapy
  • History of major urogenital malformation
  • Sleep apnea syndrome

Other

  • Contraindication to ambulatory medical care
  • Inability to understand and sign the informed consent and to complete the self-questionnaires
  • Vulnerable people

Who the study is looking for

  • Men
  • Older than 18 years old, if\> 70 years old, then patient having had a favorable onco-geriatric consultation (Balducci 2 and life expectancy\> 10 years)
  • Patient with localized prostate cancer applying for radical prostatectomy treatment
  • Patient accepting outpatient surgery
  • Radical prostatectomy performed as first-line treatment
  • BMI \<35
  • ASA score \<3
  • Accompanying person available (taxi authorized) to ensure return home
  • Have quick access to a telephone line
  • Patient who signed their informed consent
  • Patient covered by social security or other health insurance

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de NICE Pasteur 2
Coordinator of this site? Confirm its status
NiceFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.